Initial antibiotic therapy for lower respiratory tract infection in the community: A European survey

European Respiratory Journal

Volumn 9, Issue 8, 1996, Pages 1590-1595

  Huchon, G J ^a,g   Gialdroni Grassi, G ^b   Leophonte P ^c   Manresa, F ^d   Schaberg, T ^e   Woodhead, M ^f  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b UNIVERSITY OF PAVIA   (Italy)

^c UNIVERSITÉ DE TOULOUSE   (France)

^d HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^e MARTIN LUTHER KRANKENHAUS   (Germany)

^f MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^g HÔPITAL AMBROISE PARÉ   (France)

Author keywords

Acute bronchitis; Antibiotic; Community acquired pneumonia; Exacerbation of chronic bronchitis; Lower respiratory tract infection; Viral infection

Indexed keywords

AMINOPENICILLIN; CEPHALOSPORIN DERIVATIVE; MACROLIDE; PENICILLIN G; TETRACYCLINE;

ANTIBIOTIC THERAPY; ARTICLE; COMMUNITY CARE; FRANCE; GERMANY; HUMAN; ITALY; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; PRESCRIPTION; PRIORITY JOURNAL; SPAIN; UNITED KINGDOM;

EID: 0029775899     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.96.09081590     Document Type: Article

References (27)

1. Fang GD, Fine M, Orloff J, et al. New and emerging etiologies for community-acquired pneumonia with implications for therapy: a prospective multicenter study of 359 cases. Medicine 1990; 69: 307-316.
2. Niederman MS, Bass JB, Campbell GD, et al. Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity and initial antimicrobial therapy. Am Rev Respir Dis 1993; 148: 1418-1426.
3. Ortqvist A. Antibiotic treatment of community-acquired pneumonia in clinical practice: a European perspective. J Antimicrob Chemotherapy 1995; 35: 205-212.
4. Woodhead MA, Macfarlane JT, McCracken JS, Rose DH, Finch RG. Prospective study of the aetiology and outcome of pneumonia in the community. Lancet 1987; 1: 671-674.
5. Macfarlane JT, Colville A, Guion A, Macfarlane RM, Rose DH. Prospective study of aetiology and outcome of adult lower respiratory tract infections in the community. Lancet 1993; 341: 511-514.
6. Jokinen C, Heiskanen L, Juvonen H, et al. Incidence of community-acquired pneumonia in the population of four municipalities in Eastern Finland. Am J Epidemiol 1993; 137: 977-988.
7. Klugman KP. Pneumococcal resistance to antibiotics. Clin Microbiol Rev 1990; 3: 171-196.
8. Fienberg SE. The analysis of cross-classified categorical data. Cambridge, Massachusetts, M.I.T. Press, 1977.
9. Zar JH. Biostatistical analysis. Englewood Cliffs, N.J., Prentice-Hall, 1996.
10. Dixon WJ, Brown MB, Engelman L, et al. BMDP Statistical software manual. Berkeley, California, University of California Press, 1990.
11. Halls GA. The management of infections and antibiotic therapy: a European survey. J Antimicrob Chemother 1993; 31: 985-1000.
12. Fourestié V, Perbost M, Rauss A. Société de réanimation de langue française, editors. Actualités en réanimation et urgence. Conduite thérapeutique initiale dans les pneumonies communautaires: résultat d'une enquête d'opinion dans les services d'urgences français. Paris, Arnette S.A., 1993; pp. 157-175.
13. Kappstein I, Daschner FD. Antibiotic usage in community-acquired pneumonia: results of a survey in 288 departments of internal medicine in German hospitals. Infection 1991; 19: 301-304.
14. Guglielmo L, Leone R, Moretti U, Conforti A, Spolaor A, Velo G. Antibiotic prescribing patterns in Italian hospital inpatients with pneumonia, chronic obstructive pulmonary disease, and urinary tract infections. Ann Pharmacother 1993; 27: 18-22.
15. Hosker HSR, Jones GM, Hawkey P. Management of community acquired lower respiratory tract infection. BMJ 1994; 308: 701-705.
16. Hosker HSR, Cooke NJ, Hawkey P. Antibiotics in chronic obstructive pulmonary disease. BMJ 1994; 308: 871-872.
17. Anthonisen NR, Manfreda MD, Warren MD, Hershfield MD, Hording GKM, Nelson NA. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 1987; 106: 196-204.
18. Saint S, Bent S, Vittinghoff E, Grady D. Antibiotics in chronic obstructive pulmonary disease exacerbations: a meta-analysis. JAMA. 1995; 273: 957-960.
19. Friedland IR, McCracken GH. Management of infections caused by antibiotic-resistant Streptococcus pneumoniae. N Engl J Med 1994; 331: 377-382.
20. Geslin P. Résistance du pneumocoque aux antibiotiques. Bull Epid Hebd 1992; 34: 29-31.
21. Dabernat H. Centre national de référence pour Haemophilus influenzae: rapport d'activités, 1990. Bull Epid Hebd 1991; 33: 140-141.
22. Kayser FH, Morenzoni G, Santanam P. Pattern of antibiotic resistance in Haemophilus influenzae in Europe. Eur Respir Rev 1992; 2: 176-181.
23. SPILF (Société de Pathologie Infectieuse de Langue Française). Infections des voies respiratoires. Conférence de consensus en thérapeutique anti-infectieuse. Rev Med Infect 1991; 21: 1s-8s.
24. SEPAR (Spanish Thoracic Society). National recommendation for diagnosis and treatment of community-acquired pneumonia. 1992.
25. BTS (British Thoracic Society). Guidelines for the management of community-acquired pneumonia in adults admitted to hospital. Br J Hosp Med 1993; 49: 349-350.
26. Gialdroni-Grassi G, Branchi L. Guidelines for the management of community-acquired pneumonia in adults. Monaldi Arch Chest Dis 1995; 50: 21-27.
27. Schaberg T, Lode H. Antibiotische Therapie der ambulant erworbenen Pneumonien. Dtsch Med Wschr 1991; 116: 1917-1920.